U.S. Medical Equipment Stock News

Fed rate hikes, sticky 3.5–4% inflation and higher borrowing costs are reshaping where reliable income might come from, especially as growth stocks feel the heat from higher-for-longer policy into 2027. That mix creates a window for dividend investors who want cash returns without leaning on guesswork about fast expansion stories. This article walks through three high-quality dividend stocks exposed to these macro shifts and what that could mean for your portfolio. The three stocks covered...

DPC Holdings (NYSE:DPC) has just overhauled its borrowing structure, securing a new US$325 million unsecured revolving credit facility and refinancing pre IPO debt. This move reshapes its liquidity profile. Investors have reacted cautiously to these financing moves, with DPC Holdings’ 1 month share price return down 18.52% and the year to date share price return down 13.82%. This is despite a 2.23% gain over the last trading day, which hints at stabilising momentum. Scan how lenders react to...

OSI Systems reported that, earlier this week, its Security division received about US$90 million in U.S. Government orders for RF communication products and its Optoelectronics and Manufacturing unit secured roughly US$8 million of electronic assembly work from a global industrial technology client. The twin order wins highlight OSI Systems' exposure to government infrastructure programs and its ability to supply complex assemblies across multiple industrial product lines and...

Terreno Realty Corporation has executed early renewals on leases for three Sunnyvale industrial buildings totaling 172,000 square feet with a leading molecular diagnostic testing provider, extending the lease expiries from March 2030 to March 2035. The five year extension with a single specialized tenant highlights Terreno Realty's ability to keep mission critical space occupied, which can support more predictable rental income from its Sunnyvale cluster. We will now examine how Terreno...

Energy supply routes are under strain, inflation has central banks on edge, and global trade patterns are being redrawn in real time. That mix is pushing risks tied to tankers, offshore platforms, and cargo into sharper focus, and insurance stocks linked to those flows are suddenly on many watchlists. This article walks through three stocks from our Global Energy Infrastructure and Shipping Insurance screener that appear positively exposed to these shocks and explains what could be driving...

Taiwan Semiconductor Manufacturing (NYSE:TSM) reports record revenue alongside higher capital spending as it advances leading edge chipmaking. The foundry begins commercial 2nm production while relying on ASML equipment that remains without a direct competing supplier. Management outlines a larger budget for advanced manufacturing capacity that targets future high performance computing and AI workloads. TSMC's record top line and 2nm ramp tell only part of how its plans intersect with ASML's...

Westlake Corporation reported a second quarter turnaround, generating net income of US$260 million and shifting its Performance and Essential Materials segment from a US$318 million operating loss to US$185 million in operating income, supported by a 14% year over year rise in average sales prices. The group also reduced debt by US$500 million and returned US$99 million through dividends and buybacks, which highlights how Westlake is using the earnings recovery to clean up its balance sheet...

Structure Therapeutics (GPCR) has put fresh clinical data at the center of its story, with new results from ACCG-2671 and aleniglipron in chronic weight management drawing investor attention this month. The fresh trial readouts arrive after a sharp pullback in Structure Therapeutics’ 1 month share price return, which fell 34.43%. This contributed to a 48.47% share price decline year to date, even as the 1 year total shareholder return is 51.10%, a mix that suggests recent enthusiasm has...

Acushnet Holdings (GOLF) is under renewed scrutiny after a recent pullback, with the share price down about 9% over the past month and roughly 24% over the past 3 months. The recent slide in Acushnet Holdings’ share price has softened short term momentum, yet the latest close at US$81.55 still sits against a backdrop of positive total shareholder return of 9.11% over one year and 72.58% over five years. This suggests that recent weakness reflects shifting sentiment on near term risks rather...

Pfizer (PFE) heads into the Morgan Stanley Global Healthcare Conference on 14 September with investors watching for fresh commentary from CEO Albert Bourla as the stock trades near US$27.64. Pfizer’s recent 90 day share price return of 9.64% and year to date share price return of 9.77% suggest improving momentum. The 1 year total shareholder return of 22.48% contrasts with a weaker 5 year total shareholder return, indicating a recovery story that investors are reassessing as new products,...

Upwork (UPWK) has drawn fresh attention after recent trading left the stock around $8.52, with returns mixed across different time frames. Investors are weighing this move in light of the platform's role in global freelance and remote work demand. Recent trading paints a split picture for Upwork. The 90 day share price return is up 5.78%, yet the year to date share price move is down 57.08%, and the 1 year total shareholder return has declined 56.56%. This signals fading longer term momentum...

Intuitive Surgical (ISRG) just secured CE mark approval for transvaginal gynecologic procedures on its da Vinci SP system in Europe, a world first that broadens the platform’s minimally invasive surgery footprint. That regulatory win lands at an interesting moment for Intuitive Surgical, with the stock at US$383.54 after a 6.4% 7-day share price return but a year-to-date share price decline of 31.75%, while the 3-year total shareholder return of 34.88% points to much stronger longer run...

Becton Dickinson (BDX) is back under the regulatory spotlight after a December 2024 SEC order found repeated misstatements around risks tied to its Alaris infusion pump, resulting in a US$175m civil penalty. The recent SEC order lands at a time when Becton Dickinson’s share price has already been through a sharp swing, with a 90 day share price return of 25.98%, a year to date share price decline of 6.96%, and a relatively modest 5 year total shareholder return of 2.03% that contrasts with a...

Mission Produce (AVO) just paired a sharp jump in third quarter revenue with new avocado production guidance and an updated synergy target from its Calavo deal, giving investors fresh numbers to reassess the stock. The fresh production guidance and synergy update land after a choppy stretch for Mission Produce’s stock, with the share price down 5.9% over the past week and 4.7% over the past month. The stock still shows a 90-day share price return of 8.4% and a 3-year total shareholder return...

Concentra Group Holdings Parent (CON) is back in focus after another earnings beat and the launch of a new occupational health center in Daytona Beach, Florida, a move tied directly to Florida network expansion. The latest Daytona expansion and leadership succession news arrive as Concentra Group Holdings Parent trades at US$35.53, with the share price return up 24.4% over 90 days and 83.1% year to date. The 1-year total shareholder return is 70.7%, suggesting momentum has been building...

FMC Corporation (FMC) moved into the spotlight after announcing that two RNA-based bioinsecticide candidates with AgroSpheres are progressing into global field trials across the United States, Brazil and Asia. For FMC, the RNA bioinsecticide milestone is landing against a weak price backdrop, with the share price down 28.87% year to date and posting a 1-year total shareholder return decline of 71.61% as dividend cuts and past setbacks continue to weigh on sentiment. Over three and five years,...

Attention on Dave (DAVE) has picked up as investors focus on the upcoming CashAI v5.5 rollout, which is expected to influence credit performance, advance sizes, loss rates, and overall profitability for the platform. Recent trading reflects that optimism. Dave’s 1 month share price return of 7.01% and 90 day share price return of 13.37% sit alongside a 62.42% year to date share price gain, while the 3 year total shareholder return is very large, which points to strong momentum built over...

Arthur J. Gallagher has given long term shareholders a 67.0% gain over the past 5 years, even though the share price has fallen over the past year. That track record puts the spotlight on a simple question for today’s buyers and holders: whether the current valuation can be explained by the returns the business earns on its capital. A 67.0% return over 5 years means Gallagher has already rewarded patient investors, which raises the bar for how strong its future capital returns need to be to...

JPMorgan Chase (NYSE:JPM) is expanding its digital assets team to build blockchain-based banking tools for Chase customers. The bank is rolling out new consumer-facing services that apply blockchain technology to everyday retail banking activities. Chase's Ultimate Rewards program now lets customers invest reward points directly into J.P. Morgan investment accounts. These hires and the new Invest Your Points feature only capture part of how JPMorgan is reshaping future retail finance...

Arcutis Biotherapeutics used a recent Morgan Stanley healthcare conference to reaffirm its 2026 revenue guidance of US$525 million to US$540 million and confirmed that the Phase 2 vitiligo trial remains scheduled for a fourth quarter data readout. This combination of steady revenue guidance and an on track dermatology pipeline update gives investors a clearer view of how Arcutis Biotherapeutics is trying to balance commercial execution with R&D progress. This article examines how Arcutis...

Honeywell Aerospace shares have climbed recently after a weak start to the year, which puts fresh attention on whether the current market price lines up with what the business can generate in cash over time. For investors watching the swings, the key issue is whether the stock’s recent move is backed up by the company’s underlying cash flows. The stock is still down 16.4% year to date, so the recent rebound raises the question of whether the current valuation now properly reflects the cash...

Blackstone has seen its share price fall sharply over the past year, which puts a spotlight on a different question for you as an investor. Is the current market value still in line with the returns the asset manager earns on the capital it puts to work across credit, private equity and real assets? The stock is down 30.8% over the past year, which raises the question of whether that decline now matches the returns Blackstone is generating on its invested capital. Recent moves to acquire...

Macy's (M) just paired a fresh quarter of earnings with updated guidance and a completed multiyear buyback, giving investors a dense cluster of new numbers to dissect around the stock. At around $21.64 per share, Macy's has slipped over the past month and quarter, with the 30 day and 90 day share price returns down 6.84% and 10.36%. At the same time, the 1 year total shareholder return of 27.25% and 3 year total shareholder return of about 2.3x hint that investors who stayed through earlier...

Constellation Energy (CEG) has moved into the spotlight after filing a detailed protest with the Federal Energy Regulatory Commission that challenges PJM’s proposed Interim Resource Adequacy Service and Large Load Registry framework. Recent trading in Constellation Energy reflects this push and pull between strong nuclear and data center demand tailwinds and fresh regulatory and acquisition headlines. The share price closed at US$262.8, with a 1-day share price return of 1.26%. However, the...